JACOBS LEVY EQUITY MANAGEMENT, INC - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$56,000
-58.2%
133,607
+99.4%
0.00%
-50.0%
Q3 2018$134,000
-34.0%
67,008
-30.1%
0.00%
-33.3%
Q2 2018$203,000
+222.2%
95,908
+311.2%
0.00%
+200.0%
Q1 2018$63,000
+3.3%
23,323
+41.1%
0.00%0.0%
Q4 2017$61,000
-15.3%
16,527
+0.7%
0.00%0.0%
Q3 2016$72,00016,4180.00%
Other shareholders

There were no reported owners of SUNESIS PHARMACEUTICALS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of SUNESIS PHARMACEUTICALS INC shareholders